JNJ-64042056

· Janssen Pharmaceutica N.V.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JNJ-64042056, covering 2026-02-17 to 2026-02-17. Get the full timeline:

Most recent: Clinical Trial Update: A Study of JNJ-64042056 in Participants With Preclinical Alzheimer's Disease [Phase 2]